DBVT
INTERIM CONDENSED STATEMENT OF CONSOLIDATED FINANCIAL POSITION (Amounts in euros) 06/30/2015 12/31/2014 ASSETS Non-Current assets Intangible assets 48,507 28,835 Property, plant, and equipment 2,291,170 2,224,928 Other n BiopharmaWatch Research Key Takeaway: INTERIM CONDENSED STATEMENT OF CONSOLIDATED FINANCIAL POSITION
06/30/2015 12/31/2014 ASSETS Non-Current assets Intangible assets 48,507 28,835 Property, plant, and equipment 2,291,170 2,224,928 Other non-current financial assets 1,995,787 1,
BiopharmaWatch Analysis From our catalyst data and publicly available data · not financial advice Best trade, last catalyst
+12%
120-day peak, hindsight
Typical move
14%
average across 3 past catalysts
Cash runway
~9 mo
Medium dilution risk
Lead asset
DBV712
Phase 3 · Peanut Allergy
Full Press Release Details INTERIM CONDENSED STATEMENT OF CONSOLIDATED FINANCIAL POSITION
06/30/2015 12/31/2014 ASSETS Non-Current assets Intangible assets 48,507 28,835 Property, plant, and equipment 2,291,170 2,224,928 Other non-current financial assets 1,995,787 1,595,861 Total non-current assets 4,335,464 3,849,624 Current assets Inventories and work in progress 137,840 124,071 Customer accounts receivable and related receivables 136,112 Other current assets 9,996,529 6,722,563 Cash and cash equivalents 104,534,659 114,583,141 Total Current Assets 114,669,028 121,565,887 TOTAL ASSETS 119,004,492 125,415,511
06/30/2015 12/31/2014 LIABILITIES Shareholders equity Share Capital 1,966,166 1,916,066 Premiums related to the Share Capital 166,412,624 163,876,789 Reserves (48,262,509 ) (26,336,016 ) Net Profit (loss) (14,478,149 ) (24,011,880 ) Total Shareholders equity 105,638,132 115,444,959 Non-Current Liabilities Long-term financial debt 4,722,318 3,888,170 Non-current provisions 731,270 530,732 Total non-current Liabilities 5,453,588 4,418,902 Current Liabilities Short-term financial debt 148,912 212,736 Current Provisions 156,061 Bank overdrafts 27,956 Supplier Accounts Payable and Related Payables 4,690,730 1,874,629 Other current liabilities 2,917,069 3,436,329 Total Current Liabilities 7,912,772 5,551,650 TOTAL LIABILITIES AND SHAREHOLDERS EQUITY 119,004,492 125,415,511
Tags: DBVT Viatris Investor Conferences Healthcare investor conferences healthcare conferences UBS Global Healthcare